EcoDrugPlus

Histone Deacetylase 5

Ensembl ID : ENSCPOG00000025458
Gene Symbol: HDAC5
4 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSCPOG00000008955
Gene Symbol: HDAC6
4 Cross references
183 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSCPOG00000006013
Gene Symbol: HDAC7
2 Cross references
263 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSCPOG00000005671
Gene Symbol: HDAC8
4 Cross references
204 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSCPOG00000005468
Gene Symbol: HDAC9
2 Cross references
233 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSCPOG00000005596
Gene Symbol: HSD11B1
2 Cross references
267 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSCPOG00000022685
Gene Symbol: HCN4
2 Cross references
288 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSCPOG00000007144
Gene Symbol: HCRTR1
2 Cross references
95 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSCPOG00000006205
Gene Symbol: HCRTR2
2 Cross references
199 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSCPOG00000014771
Gene Symbol: IDO1
2 Cross references
98 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSCPOG00000010558
Gene Symbol: IKBKB
2 Cross references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSCPOG00000006264
Gene Symbol: IMPDH1
4 Cross references
335 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).